Urtica parviflora
Urtica parviflora · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Urtica parviflora is a distinctive herbaceous species belonging to the Urticaceae family. This plant is characterized by its unique morphology and specific ecological requirements within its natural habitat. Researchers have taken a keen interest in its chemical profile, particularly through the development of methanolic extracts. These preparations serve as a vital tool for isolating bioactive compounds for further pharmacological study. Understanding the properties of these extracts is essential for unlocking the therapeutic potential of the species.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Urticaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Urtica parviflora is most commonly recognized by its descriptive name, the Smooth-Leaf Himalayan Nettle. Unlike many of its stinging relatives, this specific species is characterized by its lack of irritating hairs on the foliage. This unique physical trait makes it a distinct member of the nettle family found throughout high-altitude regions. Identifying the plant by its common name helps botanists and enthusiasts quickly distinguish it from more aggressive varieties. Understanding these subtle differences is essential for anyone studying the diverse flora of the Himalayas.
Sources: Catalogue of Life (COL)
Taxonomy
Urtica parviflora belongs to the expansive kingdom Plantae, serving as a fundamental part of the botanical world. Within this vast kingdom, the species is classified under the class Equisetopsida. It further resides within the order Rosales, which helps define its evolutionary placement. The plant is a member of the Urticaceae family, a group known for distinct botanical characteristics. Ultimately, it is identified by its specific genus, Urtica, which connects it to its close relatives.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Rosales |
| Family | Urticaceae |
| Genus | Urtica |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Urtica parviflora displays a diverse geographic range that spans across several distinct Asian regions. In the temperate zones of Asia, the species is notably documented throughout various parts of China, including the South-Central provinces. Its presence extends into tropical Asian climates, where it is found across the expansive Indian Subcontinent. Specifically, the plant thrives within the unique ecosystems of the East, West, and Nepal Himalayan ranges. This widespread distribution highlights the species' ability to adapt to both temperate and tropical mountain environments.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Biological Activities
Compounds
Conditions
Urtica parviflora demonstrates significant potential in treating bacterial threats by exhibiting both antibacterial and antibiofilm activity. Specifically, its methanolic extracts target pathogenic and strong biofilm-producing strains of Escherichia coli. The plant is effective at inhibiting the formation of biofilms, which are protective layers that typically increase microbial resistance to antibiotics. While its MIC values are classified as moderate to poor, it remains a notable candidate for managing uropathogenic bacteria. Consequently, Urtica parviflora serves as a valuable source for developing future antibiotic treatments against biofilm-associated infections.
Preparations
Urtica parviflora is prepared as methanolic extracts to evaluate its medicinal properties. These specific extracts were tested for their ability to inhibit biofilm formation caused by various uropathogenic Escherichia coli strains. Through this preparation, the plant demonstrated both antibacterial and antibiofilm activities against strong biofilm-producing microbes. The study noted that the methanolic extracts of Urtica parviflora yielded a moderate to poor minimum inhibitory concentration value. Consequently, these prepared extracts are considered potential candidates for future antibiotic development.